Literature DB >> 26798478

Outcomes of dialysis catheters placed by the Y-TEC peritoneoscopic technique: a single-center surgical experience.

Yorg Al Azzi1, Etti Zeldis1, Girish N Nadkarni1, Harry Schanzer2, Jaime Uribarri1.   

Abstract

BACKGROUND: In the last few years, peritoneal dialysis (PD) catheter placement techniques and outcomes have become important because of the growing population of PD patients. Although there are a growing number of catheters placed by the minimally invasive Y-TEC peritoneoscopic technique, there are still limited data on outcomes for these catheters, especially those placed by a surgeon. We aimed to conduct a retrospective study of our experience with PD catheters placed by the Y-TEC peritoneoscopic technique in our institution.
METHODS: We reviewed patients with peritoneoscopic PD catheter insertion over the last decade and described their complications and outcomes. In a secondary analysis, we compared the outcomes and complications of these catheters with those with open placement placed by the same surgeon.
RESULTS: We had complete data on 62 patients with peritoneoscopic catheter placement during the study period. The mean age was 55 years, 48.4% were females and the most common cause of end-stage renal disease was diabetes mellitus (33%). Surgical complications were seen in only 6/62 (9.6%) and peritonitis in 16/62 (26%) of peritoneoscopic catheters. Most catheters were used after 2 months of placement, while 12.3% were used within 2 months. When compared with 93 patients with open placement of catheters as a secondary analysis, peritoneoscopic catheters were found to have a higher 2-year survival.
CONCLUSION: Our large series of peritoneoscopically placed catheters by a surgeon demonstrate low surgical complications and peritonitis rates as well as superior 2-year survival compared with open placement of catheters.

Entities:  

Keywords:  CAPD; catheter; peritoneal dialysis; peritoneal membrane; peritoneoscopy

Year:  2015        PMID: 26798478      PMCID: PMC4720193          DOI: 10.1093/ckj/sfv113

Source DB:  PubMed          Journal:  Clin Kidney J        ISSN: 2048-8505


Introduction

Peritoneal dialysis (PD) has become a modality of choice for renal replacement therapy (RRT) for many end-stage renal disease (ESRD) patients requiring autonomy and having a busy lifestyle [1-6]. The PD catheter is the cornerstone of PD and its proper function and survival are crucial. In the last few years, PD catheter placement techniques and outcomes have been the subject of several publications in the medical literature. Meta-analyses and systematic reviews have suggested that straight catheters tend to have less migration than coiled catheters [7-9]. Another important issue described in the recent literature is the improved results with fewer malfunctions and longer catheter survival found when performing the procedure with a classic laparoscopic technique using the several ports approach under general anesthesia [10]. However, there are still limited data on the outcomes of catheters placed by the minimally invasive Y-TEC peritoneoscopic technique. In the present study, we review our experience with these catheters over the past decade in a large population of PD patients. We also compared outcomes for these catheters with those placed by the classic open technique.

Materials and methods

Data collection

We performed a retrospective chart review of all ESRD patients who had a PD catheter inserted at Mount Sinai Hospital from 2004 to 2014. We only included the first instance of catheter placement for each patient. We performed a comprehensive chart review and abstracted demographics, comorbidities including diabetes mellitus and whether PD was the first RRT modality. We reviewed the operative notes and abstracted information on the surgical approach (peritoneoscopic versus open) and the time for first use after insertion. We also collected information on complications (mechanical/infectious/other), overall catheter survival and total time of follow-up (including when the patient discontinued PD due to inability/transplant/preference). The institutional review board of our institution approved the study.

Techniques of catheter implantation

Y-TEC peritoneoscopy technique

Under local anesthesia with mild sedation, a 2-cm paraumbilical paramedian incision is made in the skin and subcutaneous tissue, exposing the anterior rectus fascia. A 0 Prolene purse-ring stitch is placed in the fascia. Through the center of this purse-ring stitch, a Varis needle is introduced and 3 L of nitrous oxide is insufflated into the peritoneal cavity. This gas is used instead of CO2 because it is painless in the peritoneal cavity and allows for the procedure to be performed under local anesthesia. Once pneumoperitoneum is obtained, the Varis needle is removed and a Y-TEC trocar is introduced through the center of the purse ring. This trocar has a metallic cannula/peeling sheath that accepts the Y-TEC scope. Peritoneoscopy is done and the tip of the cannula/peeling sheath is directed toward the pelvis. The metallic cannula is removed, leaving the peeling sheath in place. The PD catheter, which is mounted on a rigid metallic rod, is introduced through the peeling sheath and as the catheter is being introduced, the rod is progressively removed. Before removing the peeling sheath, the distal Dacron cuff is forced into the rectal sheet. The purse-ring suture is tightened snugly around the catheter. The external side of the catheter is brought out through a small superior lateral skin opening, leaving the proximal Dacron cuff subcutaneously.

Open technique

Under general anesthesia, a 5–10 cm long paraumbilical paramedian incision is made in the skin and subcutaneous layers. The anterior rectus muscle fascia is opened in the same direction and extension. The muscle fibers are split, exposing the posterior fascia/peritoneal membrane. A 0 Prolene purse-ring stitch is placed in this layer and in the center of it, a small opening is made. The PD catheter is introduced through this opening, directing the tip of the catheter to the pelvic area. The distal Dacron cuff is positioned outside of the posterior fascia/peritoneal membrane and the purse-ring suture is tightly tied around the catheter. The anterior rectus fascia is closed with a continuous 0 Prolene suture. The catheter is exited through a small skin incision superior/lateral, leaving the proximal Dacron cuff in the subcutaneous layer.

Statistical analysis

We summarized differences in continuous variables using mean/median values depending on their distribution and categorical variables using percentages. We utilized t-test/Wilcoxon rank-sum test for continuous and χ2 test for categorical variables to assess differences between patients who lost their catheters versus those who did not. As a secondary analysis, we analyzed the independent effect of the peritoneoscopic versus open placement technique using Cox proportional hazard modeling after adjusting for demographics and comorbidities. We censored follow-up time at death, transfer to hemodialysis (with a functioning PD catheter) or loss to follow-up. We constructed Kaplan–Meier curves to plot catheter survival over the follow-up period. We used a two-tailed P-value ≤0.05 to determine statistically significant differences. All statistical analyses were performed using STATA 12 SE (StataCorp, College Station, TX, USA).

Results

Baseline characteristics

From February 2004 to June 2014, a total of 155 ESRD patients had their first PD catheters inserted at the Icahn School of Medicine at Mount Sinai. Table 1 summarizes patients' baseline characteristics both overall as well as stratified by the type of catheter placement. The mean age was 55 years, 51% were males and 63.2% of patients were white. Diabetes mellitus was the most common cause of ESRD in our population, followed by hypertension and chronic glomerulonephritis/HIV-associated nephropathy (HIVAN). PD was the first modality of RRT in 103 (66.5%) patients. In 130 (83.9%) patients, catheters were used after 2 months of insertion, whereas in 19 (12.3%) patients, catheters were used <2 months, mostly in the setting of urgent-start PD. Three catheters had primary nonfunction, one was never used because the patient expired 5 days after PD catheter placement and one was never used because the patient was never started on PD. With the exception of lower body mass index in patients with peritoneoscopic placement, there were no significant differences in baseline characteristics by catheter placement technique.
Table 1.

Baseline characteristics of patients overall and stratified by catheter loss (n = 155)

OverallPatients with Y-TEC peritoneoscopic catheter placement (n = 62)Patients with open catheter placement (n = 93)P-value
Age (years), mean (SD)55.1 (17.1)56.5 (17.9)54.2 (16.6)0.42
Male, n (%)79 (51)36 (59)42 (45.2)0.09
Race, n (%)0.39
 White98 (63.2)36 (59)58 (62.4)0.68
 African American/other57 (36.8)24 (41)35 (37.6)
Body mass index, median (IQR)26 (23–30)25 (22–28)27.5 (24–32)0.02
Cause of ESRD, n (%)0.10
 Diabetes50 (32.3)13 (21.3)37 (39.8)
 Hypertension35 (22.6)18 (29.5)16 (17.2)
 Glomerulonephritis/HIVAN37 (23.9)17 (27.9)20 (21.5)
 Other33 (21.3)14 (21.5)20 (21.5)
PD as first modality103 (66.5)42 (67.7)60 (64.5)0.58
Time to first use, n (%)0.10
 ≥2 months130 (83.9)48 (77.4)82 (88.1)
 <2 months19 (12.3)10 (16.1)9 (9.7)
 Unknown/never used6 (3.8)4 (6.5)2 (2.2)
Prior abdominal surgery, n (%)30 (0)3 (3.2)0.17

Other causes of ESRD included interstitial nephritis (n = 2), amyloidosis (n = 2), medication induced (n = 6), polycystic kidney disease (n = 5), congenital (n = 3), sickle-cell disease (n = 1), chronic rejection post-transplant (n = 1), acute kidney injury (n = 2) and unknown (n = 11).

IQR, interquartile range; HIVAN, HIV-associated nephropathy.

Baseline characteristics of patients overall and stratified by catheter loss (n = 155) Other causes of ESRD included interstitial nephritis (n = 2), amyloidosis (n = 2), medication induced (n = 6), polycystic kidney disease (n = 5), congenital (n = 3), sickle-cell disease (n = 1), chronic rejection post-transplant (n = 1), acute kidney injury (n = 2) and unknown (n = 11). IQR, interquartile range; HIVAN, HIV-associated nephropathy.

Complications and outcomes

The infectious and noninfectious complications of patients with catheters placed by Y-TEC peritoneoscopic techniques are shown in Table 2. The most common infectious complication was peritonitis, which occurred in 26% of patients. The most common noninfectious complication was scrotal leak, occurring in 4.8% of patients. There were no complications of hernias or catheter migration seen in the Y-TEC peritoneoscopically placed catheters. During follow-up, 8 (13%) patients lost their catheters. The most common reason for catheter loss was peritonitis in three patients. Other causes included mechanical dysfunction in two patients, abdominal wall leak in one patient and pleuroperitoneal fistula in one patient. One patient had a malposition; however, a new catheter was placed immediately. When comparing survival of Y-TEC placed catheters with those placed by open technique in a secondary analysis, although this difference was not statistically significant (Table 2).
Table 2.

Infectious and noninfectious catheter complications with associated catheter loss

Total, nPatients with Y-TEC peritoneoscopic catheter placement (n = 62), n (%)Patients with open catheter placement (n = 93), n (%)P-value
Infectious complications
 Only peritonitis5516 (26)39 (42)0.05
 Exit site infection2710 (16.1)17 (18.3)0.45
 Tunnel infection113 (5)8 (8.6)0.80
Noninfectious complications
 Scrotal leak73 (4.8)4 (4.3)0.34
 Hernias30 (0)3 (3.2)0.55
 Catheter migration20 (0)2 (2.2)0.90
 Subcutaneous hematoma21 (1.6)1 (1.1)0.54
 Adhesions21 (1.6)1 (1.1)0.54
 Omental adherence21 (1.6)1 (1.1)0.54
 Pleuroperitoneal fistula10 (0)1 (1.1)0.90
Infectious and noninfectious catheter complications with associated catheter loss In a secondary analysis, comparing the survival of Y-TEC-placed catheters with those placed by the open technique, there was no difference in hazard ratios in catheter survival after adjusting for demographics, diabetes status and the number of previous catheter placements for overall follow-up. However, at 2 years of follow-up, open placement of catheters had a higher adjusted hazard ratio for catheter loss compared with Y-TEC peritoneoscopic placement [2.53 (95% CI 0.98–6.68), P = 0.06], which was close to statistical significance (Table 3.) This is likely since a majority of catheters were lost within 24 months, with the mean time to catheter loss being 18 months. The Kaplan–Meier curves for time to catheter loss are shown in Figure 1.
Table 3.

Multivariable Cox proportional hazards for catheter loss

Hazard ratio (95% CI)P-value
Peritoneoscopic placement1 (Ref)NA
Open placement2.53 (0.98–6.68)0.06
Age0.99 (0.96–1.02)0.79
Female1 (Ref)
Male1.02 (0.42–2.46)0.82
White1 (Ref)NA
African/American or other0.65 (0.25–1.72)0.39
Diabetes mellitus1.06 (0.41–2.71)0.91
Body mass index1.07 (0.99–1.16)0.08
Fig. 1.

Catheter cumulative survival stratified by placement technique. This figure shows Kaplan–Meier curves for catheter loss by catheter placement technique. The solid red line denotes open placement of catheters, while the dotted green line denotes peritoneoscopic placement over the follow-up period in months. The two vertical maroon lines denote time intervals of 1 and 2 years of follow-up.

Multivariable Cox proportional hazards for catheter loss Catheter cumulative survival stratified by placement technique. This figure shows Kaplan–Meier curves for catheter loss by catheter placement technique. The solid red line denotes open placement of catheters, while the dotted green line denotes peritoneoscopic placement over the follow-up period in months. The two vertical maroon lines denote time intervals of 1 and 2 years of follow-up.

Discussion

In this article we present one of the largest series of Y-TEC peritoneoscopically placed PD catheters by a surgeon. We report an overall catheter survival rate comparable with previous reports of laparoscopic or open placement [8, 11–13], with an average of 80% survival at 2 years. Gadallah et al. [12] showed that a peritoneoscopically placed catheter (using Y-TEC) had fewer complications and higher survival rates compared with those placed by an open technique. A recent meta-analysis showed that peritoneoscopically placed catheters had a better 1-year survival and also less catheter migration than those placed via an open approach [10]. We also observed catheter leak occurring in 4.9% of patients, which is much lower than previously described [11, 14]. Also, our rate of mechanical complications was 11%, compared with 17.8% in a recent study by Ouyang et al. [8]. Our report shows that Y-TEC peritoneoscopically placed catheters had a low complication rate and a similar survival rate compared with those placed surgically by an open technique. With regards to the type of catheter used, a recent systematic review and meta-analysis by Hagen et al. [9] favored survival of straight versus coiled PD catheters. Since all of our patients, except one, had coiled PD catheters, we are unable to compare differences in outcome between the two types of catheters. However, the fact that we did not find differences in outcome in our catheters compared with other published experiences with a greater use of straight catheters suggests that coiled catheters might be as safe. A majority of the PD catheters in the USA are placed by surgeons and by an open or laparoscopic technique. The peritoneoscopic technique has the advantage that it is done under local sedation, as opposed to a laparoscopic approach that is done with general anesthesia. Moreover, this technique allows acute use of the catheter as opposed to laparoscopy, which requires a healing time of at least 2 weeks. This report provides evidence that peritoneoscopically placed PD catheters could be utilized as a procedure of choice among surgeons providing access for PD. In summary, this decade-long, single-center experience with peritoneoscopically placed PD catheters by a surgeon demonstrated similar catheter survival rates but lower mechanical complications rates compared with previous reported studies using open or laparoscopic placement. Also of interest, coiled PD catheters showed no significant difference in outcome compared with straight catheters.

Conflict of interest statement

The authors report no conflict of interest. The results presented in this article have not been published previously in whole or in part, except in abstract format.
  14 in total

1.  Risk factors associated with peritoneal dialysis catheter survival: a 9-year single-center study in 315 patients.

Authors:  Namita Singh; Ingemar Davidson; Abu Minhajuddin; Steven Gieser; Michael Nurenberg; Ramesh Saxena
Journal:  J Vasc Access       Date:  2010 Oct-Dec       Impact factor: 2.283

Review 2.  Peritoneal dialysis: a viable renal replacement therapy option.

Authors:  Ramesh Saxena
Journal:  Am J Med Sci       Date:  2005-07       Impact factor: 2.378

Review 3.  A systematic review and meta-analysis of the influence of peritoneal dialysis catheter type on complication rate and catheter survival.

Authors:  Sander M Hagen; Jeffrey A Lafranca; Jan N M IJzermans; Frank J M F Dor
Journal:  Kidney Int       Date:  2013-10-02       Impact factor: 10.612

4.  Peritoneoscopic versus surgical placement of peritoneal dialysis catheters: a prospective randomized study on outcome.

Authors:  M F Gadallah; A Pervez; M A el-Shahawy; D Sorrells; G Zibari; J McDonald; J Work
Journal:  Am J Kidney Dis       Date:  1999-01       Impact factor: 8.860

5.  Coiled versus straight peritoneal dialysis catheters: a randomized controlled trial and meta-analysis.

Authors:  Jingyuan Xie; Krzysztof Kiryluk; Hong Ren; Ping Zhu; Xiaomin Huang; Pingyan Shen; Tian Xu; Xiaonong Chen; Nan Chen
Journal:  Am J Kidney Dis       Date:  2011-08-27       Impact factor: 8.860

6.  The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis.

Authors:  Edward F Vonesh; Jon J Snyder; Robert N Foley; Allan J Collins
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

7.  Comparing the Incidence of Catheter-Related Complications with Straight and Coiled Tenckhoff Catheters in Peritoneal Dialysis Patients-A Single-Center Prospective Randomized Trial.

Authors:  Chu-Jun Ouyang; Feng-Xian Huang; Qiong-Qiong Yang; Zong-Pei Jiang; Wei Chen; Yagui Qiu; Xue-Qing Yu
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

8.  Comparison of Percutaneous and Open Surgical Techniques for First-Time Peritoneal Dialysis Catheter Placement in the Unbreached Peritoneum.

Authors:  Samar Medani; Wael Hussein; Mohamed Shantier; Robert Flynn; Catherine Wall; George Mellotte
Journal:  Perit Dial Int       Date:  2014-07-31       Impact factor: 1.756

Review 9.  What is the place of peritoneal dialysis in the integrated treatment of renal failure?

Authors:  G A Coles; J D Williams
Journal:  Kidney Int       Date:  1998-12       Impact factor: 10.612

10.  Laparoscopic versus open peritoneal dialysis catheter insertion: a meta-analysis.

Authors:  Sander M Hagen; Jeffrey A Lafranca; Ewout W Steyerberg; Jan N M IJzermans; Frank J M F Dor
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

View more
  3 in total

Review 1.  How To Build a Successful Urgent-Start Peritoneal Dialysis Program.

Authors:  Nilum Rajora; Shani Shastri; Gulzar Pirwani; Ramesh Saxena
Journal:  Kidney360       Date:  2020-08-11

Review 2.  Peritoneal Dialysis Catheter Placement: Percutaneous and Peritoneoscopic Techniques.

Authors:  Husameddin El Khudari; Ahmed Kamel Abdel-Aal; Masa Abaza; Sloan E Almehmi; Bharat Sachdeva; Ammar Almehmi
Journal:  Semin Intervent Radiol       Date:  2022-02-18       Impact factor: 1.780

3.  An analysis of the "Half-Perc" versus open surgical placement method for a peritoneal dialysis catheter: a non-inferiority cohort study.

Authors:  Difei Zhang; Yu Peng; Tingting Zheng; Hui Liu; Jianfeng Wu; Zewen Li; Jingxu Su; Yuan Xu; Xiaoxuan Hu; Guowei Chen; Haijing Hou; Liwen Wu; Xusheng Liu; Fuhua Lu
Journal:  BMC Nephrol       Date:  2020-07-20       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.